Ottestad L, Fronth L, Rajendiran S, Hege Aksnes L, Petter Eikesdal H, Støre Blix E, et al. Observational study of everolimus plus exemestane in postmenopausal women with hormone receptor-positive, HER2-negative advanced breast cancer. AO [Internet]. 2019 Mar. 4 [cited 2025 Feb. 21];58(3):385-387 |. Available from: https://medicaljournalssweden.se/actaoncologica/article/view/24441